ASO Visual Abstract: Restrictive Intraoperative Fluid Rate Is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

被引:0
|
作者
Peng, June S. [1 ,2 ]
LaPiano, Jessica [3 ]
Wang, Katy [4 ]
Attwood, Kristopher [4 ]
Skitzki, Joseph J. [1 ]
Kane, John M., III [1 ]
Francescutti, Valerie A. [1 ,5 ]
机构
[1] Roswell Pk Comprehens Canc Ctr, Dept Surg Oncol, Buffalo, NY USA
[2] Penn State Coll Med, Dept Surg, Div Surg Oncol, Hershey, PA USA
[3] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA
[4] Roswell Pk Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA
[5] McMaster Univ, Dept Surg, Hamilton, ON, Canada
关键词
D O I
10.1245/s10434-021-10672-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:638 / 639
页数:2
相关论文
共 50 条
  • [41] ASO Visual Abstract: Improved Postoperative Pain Management Outcomes After Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)
    Yue, Tiffany M.
    Sun, Beatrice J.
    Xu, Nova
    Ohkuma, Rika
    Fowler, Cedar
    Lee, Byrne
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (07) : 4751 - 4751
  • [42] ASO Visual Abstract: Timing of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Low-Grade Appendiceal Mucinous Neoplasms
    Cristian D. Valenzuela
    Christopher W. Mangieri
    Mary Garland-Kledzik
    Rohin Gawdi
    Gregory Russell
    Kathleen C. Perry
    Konstantinos I. Votanopoulos
    Edward A. Levine
    Perry Shen
    Annals of Surgical Oncology, 2022, 29 : 3434 - 3435
  • [43] Fluid Administration and Morbidity in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Eng, O. S.
    Dumitra, S.
    O'Leary, M.
    Raoof, M.
    Wakabayashi, M.
    Dellinger, T. D.
    Han, E.
    Lee, S.
    Paz, I. B.
    Lee, B.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S78 - S78
  • [44] ASO Visual Abstract: Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Cancers with Peritoneal Metastasis—A 30-year Institutional Experience
    Cristian D. Valenzuela
    Edward A. Levine
    Christopher W. Mangieri
    Rohin Gawdi
    Omeed Moaven
    Gregory Russell
    Megan E. Lundy
    Kathleen C. Perry
    Konstantinos I. Votanopoulos
    Perry Shen
    Annals of Surgical Oncology, 2022, 29 : 3448 - 3449
  • [45] ASO Visual Abstract: Organ-specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy-A Scoping Review
    Balachandran, Rogini
    Mogensen, Louise Zinck
    Christensen, Peter
    Thaysen, Henriette Vind
    Iversen, Lene Hjerrild
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 6086 - 6086
  • [46] ASO Visual Abstract: The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Michelle V. Dietz
    Job P. van Kooten
    Jeroen L. A. van Vugt
    Alexandra R. M. Brandt-Kerkhof
    Cornelis Verhoef
    Eva V. E. Madsen
    Annals of Surgical Oncology, 2022, 29 : 5842 - 5842
  • [47] ASO Visual Abstract: The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Dietz, Michelle V.
    van Kooten, Job P.
    van Vugt, Jeroen L. A.
    Brandt-Kerkhof, Alexandra R. M.
    Verhoef, Cornelis
    Madsen, Eva V. E.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 5842 - 5842
  • [48] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes
    Robella, Manuela
    Vaira, Marco
    Cinquegrana, Armando
    De Simone, Michele
    MINERVA CHIRURGICA, 2019, 74 (03) : 195 - 202
  • [49] Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
    Gani, Faiz
    Conca-Cheng, Alison M.
    Nettles, Brenda
    Ahuja, Nita
    Johnston, Fabian M.
    JOURNAL OF SURGICAL RESEARCH, 2019, 234 : 240 - 248
  • [50] ASO Visual Abstract: Genetic Clustering of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Patients of Colorectal Origin-KRAS and Not TP53 Cluster Alterations are Associated with Poor Outcomes
    Yu, Allen T.
    Hanna, David N.
    Li, Thomas M.
    Sarfaty, Elad
    Khajoueinejad, Nazanin
    Li, Judy
    Golas, Benjamin
    Hiotis, Spiros
    Labow, Daniel
    Sarpel, Umut
    Magge, Deepa R.
    Cohen, Noah A.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 8010 - 8011